
One Fruit May Be Evolving in Reverse
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
Wild tomatoes on the Galápagos Islands are rewinding millions of years of evolution, according to a new study.
Scientists at the University of California, Riverside found that these tomatoes—descended from South American ancestors likely brought to the Pacific archipelago by birds—are producing a toxic molecular cocktail not seen in millions of years.
Biologists described this as a rare and striking case of "reverse evolution."
Adam Jozwiak, a molecular biochemist at UC Riverside and lead author of the study, told Newsweek that while "de-evolution" makes for a striking headline, what we're really seeing is evolution taking an unexpected turn, reverting to a state that existed millions of years ago.
Could something similar happen in humans? Jozwiak said in theory, yes.
A bunch of wild tomatoes growing on a plant.
A bunch of wild tomatoes growing on a plant.
Irina Khabarova
"Humans, like all organisms, are subject to evolutionary forces," Jozwiak explained.
"If environmental conditions shifted dramatically over long timescales, it's possible that traits from our distant past could re-emerge, but whether that ever happens is highly uncertain. It's speculative and would take millions of years, if at all."
The key players in this evolutionary reversal are alkaloids—chemicals that serve as built-in deterrents against pests.
Most cultivated tomatoes produce one type of alkaloid structure, but these Galápagos tomatoes have shifted toward an older chemical form—an evolutionary echo from their distant past and similar to compounds found in eggplant.
Researchers pinpointed a single enzyme, known as GAME8, that plays a central role in forming these chemicals. Normally, GAME8 adds a chemical group in a specific three-dimensional shape ('right-handed' or 'left-handed').
Mutations in GAME8 among western island tomatoes altered just a few building blocks (amino acids), flipping the shape back to the ancestral form.
The research team confirmed this by inserting the modified enzyme into tobacco plants, which then produced the ancient-style alkaloid.
The chemical shift is not random. Eastern islands, which are older and more ecologically diverse, host tomatoes making modern alkaloids.
In contrast, the harsher environments on younger, western islands seem to favor the ancestral, eggplant-like chemicals. Researchers believe the older alkaloids may offer better defense under these tougher conditions.
Jozwiak told Newsweek that the tomato species studied were wild relatives located in the Galápagos and not included in the human diet, which means there are no direct health implications for humans.
"If similar changes occurred in cultivated tomatoes, it might affect how these toxins interact with our digestive system or gut microbiome, but that's purely hypothetical," he said. "For now, this discovery is important for what it tells us about evolution, not for any immediate impact on human health."
Do you have a tip on a science story that Newsweek should be covering? Do you have a question about evolution? Let us know via science@newsweek.com.
Reference
Jozwiak, A., Almaria, M., Cai, J., Panda, S., Price, H., Vunsh, R., Pliner, M., Meir, S., Rogachev, I., & Aharoni, A. (2025). Enzymatic twists evolved stereo-divergent alkaloids in the Solanaceae family. Nature Communications, 16(1), 5341. https://doi.org/10.1038/s41467-025-59290-4

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
7 hours ago
- Newsweek
Watch: Moment Woman With ALS Recovers Voice With AI
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Debbie Lopez lost her voice to a muscle-weakening disease, but with the help of new artificial intelligence (AI) technology, she is speaking to her family again, Monroe Community Hospital (MCH) in Rochester, New York, confirmed to Newsweek. Why It Matters Lopez, who has been a patient at MCH since February, was diagnosed with ALS (amyotrophic lateral sclerosis) in 2019. ALS is a disease that affects the nerve cells in the body, causing the muscles to become weak and can lead to paralysis and loss of voice. No singular cause has been identified for most causes of ALS, with some research into factors that may be linked, such as heredity, environmental exposures, and diet, among others. About 30,000 people in the United States are living with ALS, according to estimates from the Centers for Disease Control and Prevention, which notes that tracking the disease can be challenging. AI technology is rapidly transforming society, reshaping jobs, productivity and advancements across sectors, including medicine. What to Know Several years ago, Lopez, 39, started a YouTube channel, Living with Lemons, to document her health journey, raise awareness, and provide comfort to others going through a similar experience. The channel has ended up being able to give Lopez her voice back, as speech pathologist Jaime Spencer, who provides care to Lopez at MCH explained, "We were able to get her voice from using her YouTube channel," adding, "and from there they were able to clone anything that she wants to say." The AI voice, which mirrors Lopez's, can now mimic anything Lopez types, thanks to the content from her YouTube videos and the technology's ability to replicate speech. MCH shared with Newsweek a video of Lopez breaking into a smile as she hears her voice from the device, saying in what sounds just like her, "Hi, I am Debbie Lopez." A screen grab of a Monroe Community Hospital video showing Debbie Lopez, a patient with ALS, hearing her voice from AI. A screen grab of a Monroe Community Hospital video showing Debbie Lopez, a patient with ALS, hearing her voice from AI. Monroe Community Hospital Lopez uses an Eyegaze device to control what the AI says, allowing her to direct and select items with her eyes, send messages and surf the web, among other features. "Cameras on the device track her eye movements and she can look at different parts of her monitor for either letters, words, or popular phrases or presets she has on her communications device," an MCH spokesperson told Newsweek in an email Wednesday. In the MCH video explaining Lopez's health journey and the use of the AI, Spencer said, "This new software and this new technology has been amazing because it allows patients and individuals to preserve some of the most intimate parts of them and what makes you you, is your voice." Lopez, through the AI, says in the video, "Even if I can't make a sound, I still have a voice." Lopez and her team at MCH are working on preserving her voice for her three children and family members by reading and recording some of her favorite children's books. What Happens Next Lopez remains in high spirits despite the severity of her disease, saying, "It's broken everyone who loves me and everyone I love, but it hasn't broken me," and adding, "I get to see the best in everyone." AI is increasingly being used in medical settings, from diagnostics and predictive analytics to assisted surgeries and the development of new treatments. "ALS can be pretty isolating. Patients lose function of much of their body parts. Anything that helps restore a sense of normalcy is a huge benefit," a MCH spokesperson told Newsweek.


Newsweek
10 hours ago
- Newsweek
Never-Smokers' Lung Cancer May Worsen in Areas With Air Pollution
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Lung cancer appears to mutate more in patients living in areas with higher levels of fine-particulate air pollution, such as that released by vehicles and air pollution. This is the conclusion of a study from the National Institutes of Health and the University of California, San Diego, which studied tumors in nearly 900 lung cancer patients who had never smoked. Despite this, paper author and oncologist Maria Teresa Landi of the National Cancer Institute told Newsweek, those in areas of higher air pollution "had a pattern of mutations that is typical of tumors from subjects who have smoked tobacco." Previous studies into the genomics of lung cancer have tended to focus exclusively on people who smoke tobacco, leaving a significant gap in our understanding of how the disease develops. In contrast, the new work represents the largest-ever whole-genome study of lung cancer patients who have never smoked—who account for 25 percent of all lung cancer cases worldwide—and could help us identify new ways to protect against the condition. The findings, the team writes, are "underscoring the importance of environmental mutagenic factors in shaping the lung cancer genomes of never smokers." An artist's impression of lung cancer and DNA. An artist's impression of lung cancer and DNA. Rasi Bhadramani/iStock / Getty Images Plus In their study, the researchers analyzed lung tumors found in 871 patients, none of whom had ever smoked, as part of the international Sherlock-Lung study. The team then cross-referenced the geographic locations of each patient with measurements of PM 2.5 air pollution—particulate matter less than 2.5 micrometers in diameter, or about forty times thinner than the average human hair—sorting each subject into high and low levels of air pollution. The researchers found associations between air pollution exposure and mutations in several genes that were previously linked with tobacco smoking. These included changes in the tumor-suppressing "TP53" gene. Alongside this, the team noted a relationship between air pollution exposure and the premature shortening of "telomeres", sections of DNA found at the end of chromosomes that act like the protective aglets at the end of shoelaces. Telomeres naturally shorten every time they are involved in cellular divisions and when they get too short, they become unable to replicate and die. Shorter telomeres are associated with genetic instability. "Shorter telomeres are a sign of more rapid cell division, a hallmark of cancer," Landi said. She added: "This observation suggests that air pollution may be promoting the growth of lung cancer as well as causing changes that might initiate a cancer." Unexpectedly, the analysis also revealed that although exposure to secondhand smoke was associated with a slight increase in mutation rates and shortened telomeres, it did not appear to lead to an increase in cancer-driving mutations. This, the team said, suggests that secondhand smoke may present less of a risk of causing genetic mutations than air pollution. This does not mean, however, that secondhand smoke is safe. As the researchers note: "Additional non-mutagenic carcinogenesis could be contributing to the observed rise in lung cancer in those exposed to secondhand smoke." Do you have a tip on a health story that Newsweek should be covering? Do you have a question about lung cancer? Let us know via health@ Reference Díaz-Gay, M., Zhang, T., Hoang, P. H., Leduc, C., Baine, M. K., Travis, W. D., Sholl, L. M., Joubert, P., Khandekar, A., Zhao, W., Steele, C. D., Otlu, B., Nandi, S. P., Vangara, R., Bergstrom, E. N., Kazachkova, M., Pich, O., Swanton, C., Hsiung, C. A., ... Landi, M. T. (2025). The mutagenic forces shaping the genomes of lung cancer in never smokers. Nature.


UPI
11 hours ago
- UPI
Science seek to tap amazing healing powers of the mouth's interior
1 of 2 | The amazing ability of the mouth's lining to quickly heal itself without scarring is likely due to a specific cellular action that could be applied to skin wounds sustained elsewhere on the body, according to a study released Wednesday. File Photo by Molly Riley/UPI | License Photo ST. PAUL, Minn., July 2 (UPI) -- The cellular action that enables the mouth's interior lining to heal quicky and without scarring has always been a mystery but a new study suggests it may be linked to a specific "signaling pathway." That new knowledge is raising hopes the mouth lining's healing powers could be applied to other skin wounds, which take far longer to heal and often leave permanent, unsightly scars, according to a preclinical study published Wednesday by Cedars-Sinai Medical Center and University of California-San Francisco researchers. The study on mice provides evidence that the "Gas6/AXL" protein/enzyme signaling pathway is likely responsible for the mouth's amazing ability to heal itself completely from even deep bite wounds within a matter of days with no leftover scarring, the authors wrote in the journal Science Translational Medicine. Known as the oral mucosa, the mouth's interior lining heals fast and cleanly, even though it is continuously exposed to different types of microbes, abrasion from foods, motion and tension. This unique regenerative capacity is made possible by specialized gene programs activated during injury, but just how those mechanisms work has been unknown. In the study reported Wednesday, a research team led by Dr. Ophir Klein, executive vice dean of Children's Health at Cedars-Sinai and executive director of Cedars-Sinai Guerin Children's in Los Angeles, found that by manipulating levels of the AXL enzyme they could affect how wounds healed. For instance, if they inhibited AXL in mice, the healing of oral mucosa wounds worsened, making them more like skin wounds. Conversely, when they stimulated AXL in facial skin wounds, they healed more efficiently and with reduced scarring, much like the oral mucosa. Boosting the levels of AXL suppresses the expression of another protein called Focal Adhesion Kinase, or FAK, which plays a significant role in scar formation during wound healing. Should future research validate the benefits for humans, the new knowledge could aid in developing new therapies to heal skin wounds with reduced scarring, Klein said. "We are actively thinking about harnessing AXL-driven repair in both the mouth and the skin, and perhaps in other tissues as well," he told UPI in emailed comments. "One application that comes to mind is to improve healing and reduce scarring in the skin for burn victims or those with other cutaneous disorders. "Another is that there are a number of diseases of the mouth, many of them autoimmune, in which severe oral ulcers form and heal poorly or not at all. These are different from canker sores, also known as aphthous ulcers, which many people get and which typically heal on their own; the more severe ulcers are difficult to treat and cause very significant illnesses, and we currently do not have good therapies for them." A related direction for research could focus on "obtaining a deeper understanding of the effects of AXL signaling on scarring and regeneration at a molecular level, in terms of other components of the signaling pathways," Klein added. "It will also be interesting to explore the role of this pathway in other tissues and organs, and in the context of distinct injuries and perturbations --for example, physical cuts vs heat burns vs irradiation versus chemical insults." Meanwhile, a pair of recent animal studies led by the University of Arizona in Tucson similarly have shown that the use of FAK inhibitors can make skin grafts look more like healthy skin and produce less scarring, raising hopes for a potential new treatment for survivors of blast wounds, burns and other major injuries. Kellen Chen, an assistant research professor in the university's Department of Surgery and lead author of those papers, said the current Cedars-Sinai study appears to add to a mounting list of evidence that "FAK acts as a central mediator of scarring in the oral mucosa gives additional credence to the importance of this factor." Chen was not involved with the new study. "A better understanding of how the oral mucosa heals without scarring through the FAK pathway will allow us to better develop therapies to target FAK for healing in the future," he told UPI. Chen said his team has the funding to pursue Food and Drug Administration approval for a FAK inhibitor, or FAKI, hydrogel therapy and expects to conduct human trials soon. The growing evidence that wound healing can be accelerated at the cellular level "could have strong clinical implications for the treatment of severe injuries for humans and animals, especially because there are zero FDA-approved treatments that reduce scar formation," he added. "Patients with severe injuries or burns can suffer a lifetime of pain and disfigurement from scarring. The potential to heal burn injuries with regeneration, rather than scarring, would dramatically change the lives of these patients."